INOXPA INDIA PVT.LTD.

Pune- 411023,

Maharashtra, India

Inoxpa's Cutting Edge Pharma Equipments

29/03/2013

Inoxpa's Cutting Edge Pharma Equipments

 

India's leading pharmaceutical players will continue to experience revenue growth of over 20% this year, primarily led by exports and especially to the US, says a new report from India Ratings.

The US market will remain Indian pharma's main focus area in the medium to short term, mainly because of the sheer size of generic opportunities there, it says. The US generic market, now worth about $100 billion, could grow at an annual average rate of around 8%-9% in the medium term, due to patent expiries - set to be worth around $125 billion during 2013-15 - coupled with pro-generic policies.

Indian firms with robust product portfolios filings and the necessary manufacturing infrastructure are well-placed to capitalise on the upcoming generic opportunity, while President Barack Obama's Affordable Care Act (ACA) will increase demand for such products in the US, according to India Ratings, which is a Fitch Group company.

"We expect Indian players' continued focus toward the US market will also be led by the low investments required for setting up a distribution infrastructure," it adds.
The report also sees continued good growth for Indian-made generics in other developed and "pharmerging" markets, due to patent expiries and cost-cutting measures by payers. On the back of this increasing demand, exports now account for 60% of the Indian pharma sector's total revenues and they grew by an annual average of 19% between 2008 and 2012. In January-October 2012, Indian drug exports were worth 620 billion rupees, an increase of around 28% year-on-year. "We expect this trend to continue," it says.

Turning to R&D, India Ratings notes that Indian drugmakers' spending here has also been increasing year-on-year, and that, on the back of large investments, they have built a strong pipeline of products to be sold in the US.

During 2011, Indian firms accounted for 51% of total Abbreviated New Drug Application (ANDA) filings in the US, compared to 49% in 2010 and 45% in 2009, and their share of ANDA approvals increased to 37% in 2012 from 33% in 2011. 178 Indian ANDAs were approved by the US Food and Drug Administration (FDA) last year, out of a total of 476, compared with 144 out of 431 in 2011.

Besides their strong product pipelines, Indian firms' growth are also set to benefit from faster commercialisation of product filings in the US due to the Generic Drug User Fee Act (GDUFA). Implemented from October 2012, GDUFA aims to bring down approval times from 31 months at present to 10 months, the report points out.

Turning to the Indian pharma market, the study says that it accounts for 40% of domestic drugmakers’ revenues, and it believes that the growth drivers here - improving health infrastructures, wider health insurance and increasing health awareness in both rural and urban regions - remain intact. However, the government's recent decision to increase the number of drugs under official price control from 74 to 348 will have a negative impact on India's domestically-focused drugmakers, especially the multinationals, although the impact will be lower on companies which garner significant revenues from exports, it says.

Source : www.pharmatimes.com

Inoxpa India is now set to introduce its cutting edge technology in Pharma ProPack expo 2013 to cater to the growth of Indian pharma industry. In  the upcoming exhibition, Inoxpa will showcase its new Pharmaceutical CIPSLES EquipmentFermentator Equipment, pharma valveProlac HCP SWFI Pump, Multitooth mixerFlexible Impeller Pumps, Progressive Captivity Pumps, Multitooth MixerCentrifugal pumpsLobe pumpsMaturing unitsReception unitsTable for draining curd mouldsthermosealing machineBlender M-226AgitatorsManifoldsSingle seat valvesvalve accessories, silpig  etc for the public display.  Inoxpa hopes to help Indian pharmaceutical Industry to reach new heights of success.

Contact

Cookies Policy

This website uses cookies. We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. However, blocking some types of cookies may affect your experience on the site and the services we can offer. Cookies policy page

Allow all cookies
Allow selection
Necessary (2)
Preferences (0)
Statistics (7)
Marketing (11)
About cookies

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.

Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Name Provider Purpose Expiry Type
cc_cookie_accept www.inoxpa.in Stores the user's cookie consent state for the current domain 1 year HTTP
PHPSESSID www.inoxpa.in Preserves user session state across page requests. Session HTTP
collect Google Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. Session Pixel
_ga Google Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 2 years HTTP
_ga_# www.inoxpa.in Used by Google Analytics to collect data on the number of times a user has visited the website as well as dates for the first and most recent visit. 2 years HTTP
_gat_ Google Used by Google Analytics to throttle request rate 1 day HTTP
_gid Google Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 1 day HTTP
fr Facebook Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 3 months HTTP
_fbp Facebook Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 3 months HTTP
IDE Google Used by Google DoubleClick to register and report the website user's actions after viewing or clicking one of the advertiser's ads with the purpose of measuring the efficacy of an ad and to present targeted ads to the user. 1 year HTTP
ads/ga-audiences Google Used by Google AdWords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites. Session Pixel
VISITOR_INFO1_LIVE YouTube Tries to estimate the users' bandwidth on pages with integrated YouTube videos. 179 days HTTP
YSC YouTube Registers a unique ID to keep statistics of what videos from YouTube the user has seen. Session HTTP
yt-remote-cast-installed YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-connected-devices YouTube Stores the user's video player preferences using embedded YouTube video. Persistent HTML
yt-remote-device-id YouTube Stores the user's video player preferences using embedded YouTube video. Persistent HTML
yt-remote-fast-check-period YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-app YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-app YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-name YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages. You can at any time change or withdraw your consent from the Cookie Declaration on our website. Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy. Please state your consent ID and date when you contact us regarding your consent.